Daniel C. Ihde, MD | Authors

Small-Cell Lung Cancer: Treatment Progress and Prospects

May 01, 1998

Although small-cell lung cancer (SCLC) represents only 20% of all lung cancer cases in the United States, it is the most lethal subtype. Combination chemotherapy unequivocally offers the best chance for improved survival in